Surgery Partners, Inc. (SGRY)
USD 19.88
(-5.47%)
USD 19.88
(-5.47%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.65 Billion USD | -45.27% |
| 2022 | 6.68 Billion USD | 9.23% |
| 2021 | 6.11 Billion USD | 13.01% |
| 2020 | 5.41 Billion USD | 7.85% |
| 2019 | 5.01 Billion USD | 7.34% |
| 2018 | 4.67 Billion USD | 1.16% |
| 2017 | 4.62 Billion USD | 100.56% |
| 2016 | 2.3 Billion USD | 9.41% |
| 2015 | 2.1 Billion USD | 28.72% |
| 2014 | 1.63 Billion USD | 234.65% |
| 2013 | 489.07 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.61 Billion USD | -1.18% |
| 2024 Q2 | 3.87 Billion USD | 7.09% |
| 2023 Q2 | 3.94 Billion USD | 730.6% |
| 2023 Q1 | 475.1 Million USD | -92.89% |
| 2023 Q3 | 6.78 Billion USD | 71.81% |
| 2023 FY | 3.65 Billion USD | -45.27% |
| 2023 Q4 | 3.65 Billion USD | -46.06% |
| 2022 Q4 | 6.68 Billion USD | 63.28% |
| 2022 FY | 6.68 Billion USD | 9.23% |
| 2022 Q1 | 3.93 Billion USD | -35.67% |
| 2022 Q2 | 3.9 Billion USD | -0.66% |
| 2022 Q3 | 4.09 Billion USD | 4.68% |
| 2021 Q2 | 3.78 Billion USD | -0.14% |
| 2021 Q1 | 3.78 Billion USD | -30.06% |
| 2021 FY | 6.11 Billion USD | 13.01% |
| 2021 Q4 | 6.11 Billion USD | 8.63% |
| 2021 Q3 | 5.63 Billion USD | 48.96% |
| 2020 FY | 5.41 Billion USD | 7.85% |
| 2020 Q3 | 5.31 Billion USD | 46.77% |
| 2020 Q4 | 5.41 Billion USD | 1.89% |
| 2020 Q2 | 3.61 Billion USD | 5.01% |
| 2020 Q1 | 3.44 Billion USD | -31.32% |
| 2019 Q4 | 5.01 Billion USD | 2.07% |
| 2019 FY | 5.01 Billion USD | 7.34% |
| 2019 Q3 | 4.91 Billion USD | 0.54% |
| 2019 Q2 | 4.89 Billion USD | 0.2% |
| 2019 Q1 | 4.88 Billion USD | 4.38% |
| 2018 Q4 | 4.67 Billion USD | 75.7% |
| 2018 FY | 4.67 Billion USD | 1.16% |
| 2018 Q1 | 4.59 Billion USD | -0.6% |
| 2018 Q2 | 2.66 Billion USD | -41.99% |
| 2018 Q3 | 2.66 Billion USD | -0.16% |
| 2017 Q3 | 2.62 Billion USD | -1.76% |
| 2017 Q4 | 4.62 Billion USD | 76.14% |
| 2017 FY | 4.62 Billion USD | 100.56% |
| 2017 Q1 | 1.79 Billion USD | -22.31% |
| 2017 Q2 | 2.67 Billion USD | 49.18% |
| 2016 Q3 | 1.74 Billion USD | 1.85% |
| 2016 FY | 2.3 Billion USD | 9.41% |
| 2016 Q4 | 2.3 Billion USD | 31.79% |
| 2016 Q2 | 1.71 Billion USD | -0.57% |
| 2016 Q1 | 1.72 Billion USD | -18.02% |
| 2015 Q4 | 2.1 Billion USD | 11.38% |
| 2015 Q2 | 1.63 Billion USD | 0.25% |
| 2015 FY | 2.1 Billion USD | 28.72% |
| 2015 Q3 | 1.89 Billion USD | 15.69% |
| 2015 Q1 | 1.63 Billion USD | -0.35% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | 1.63 Billion USD | 234.65% |
| 2014 Q4 | 1.63 Billion USD | 0.0% |
| 2013 FY | 489.07 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | -47.994% |
| Addus HomeCare Corporation | 317.73 Million USD | -1051.033% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -2722.785% |
| Amedisys, Inc. | 940.38 Million USD | -288.904% |
| American Oncology Network, Inc. | 368.72 Million USD | -891.848% |
| Astrana Health, Inc. | 522.59 Million USD | -599.818% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | -107.254% |
| IMAC Holdings, Inc. | 1.89 Million USD | -192712.398% |
| biote Corp. | 191.84 Million USD | -1806.37% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -4961.728% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -1675.995% |
| COMPASS Pathways plc | 50.24 Million USD | -7179.024% |
| DocGo Inc. | 185.28 Million USD | -1873.867% |
| The Ensign Group, Inc. | 2.68 Billion USD | -36.451% |
| Healthcare Services Group, Inc. | 346.56 Million USD | -955.268% |
| InnovAge Holding Corp. | 247.85 Million USD | -1375.552% |
| Assure Holdings Corp. | 22.84 Million USD | -15905.952% |
| The Joint Corp. | 62.37 Million USD | -5762.873% |
| LifeStance Health Group, Inc. | 804.27 Million USD | -354.719% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -95860.235% |
| ModivCare Inc. | 1.61 Billion USD | -127.003% |
| NewGenIvf Group Limited | 1.24 Million USD | -294494.562% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -32955.037% |
| Option Care Health, Inc. | 1.9 Billion USD | -91.81% |
| P3 Health Partners Inc. | 427.3 Million USD | -755.876% |
| P3 Health Partners Inc. | 427.3 Million USD | -755.876% |
| The Pennant Group, Inc. | 394.17 Million USD | -827.809% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -401758.315% |
| Talkspace, Inc. | 23.57 Million USD | -15413.043% |
| Talkspace, Inc. | 23.57 Million USD | -15413.043% |
| The Oncology Institute, Inc. | 162.39 Million USD | -2152.068% |
| The Oncology Institute, Inc. | 162.39 Million USD | -2152.068% |